Daewoong Group Indonesia
Clinical trials sponsored by Daewoong Group Indonesia, explained in plain language.
Indonesian arm of Daewoong Pharmaceutical, a South Korean pharma company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Joint gel injection after surgery shows promise in tiny trial
Symptom relief CompletedThis study looked at whether injecting hyaluronic acid into the knee or shoulder right after arthroscopic surgery helps with recovery and pain control. Nine adults aged 18 to 60 who had scheduled arthroscopy received the injection during their procedure. Researchers measured safe…
Sponsor: Daewoong Group Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Stem cell shot for frailty? small study tests safety and promise
Symptom relief CompletedThis study tested whether a single infusion of donor stem cells is safe and could help reduce frailty in older adults aged 60 to 85. Ten participants received the cells and were monitored for six months. Researchers checked for side effects, frailty levels, quality of life, and c…
Sponsor: Daewoong Group Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC